Volodimir Olexiouk, our Director of Scientific Engagement and Data Science Team Lead, was featured on episode 205 of Cynozure‘s Hub & Spoken podcast.
In this episode, Cynozure CEO and podcast host Jason Foster speaks with Volodimir about the revolutionary intersection of artificial intelligence and pharmaceuticals, exploring how AI is transforming the landscape of drug discovery.
Tune in now and gain insights into the innovative ways AI is transforming drug discovery and shaping the future of healthcare and biotechnology.
Want to learn more about how leveraging artificial intelligence can support your research & development activities? Check out our white paper about how you can use machine learning to develop better biomarkers – a powerful tool for de-risking drug discovery projects.
AI has quickly become part of everyday biotech research, helping scientists navigate information, write code and make sense of complex data. But chat-based tools have their limits. They can provide answers and guidance, but they cannot always do the actual scientific work. As biotech moves beyond the chatbox, the next step is putting AI to work directly within research workflows.
BioLizard is proud to have received the Best Poster Award at the European Society for Spatial Biology (ESSB) conference, recognising our work on benchmarking cell segmentation methods for single-cell spatial transcriptomics.
KMOinsider and Netwerkers.be, host a panel of four perspectives on leadership, with discussions spanning strategy, communication, trust, autonomy and the role of people in organisational growth.
